As Autumn Begins, Brazil Braces for a Rise in Respiratory Illnesses

Overview

• Fiocruz’s InfoGripe reports an upward trend in severe acute respiratory infections across nearly all states, with recent lab confirmations led by rhinovirus (~41%), influenza A (~21%), SARS‑CoV‑2 (~16%) and RSV (~14%).
• Health services expect heavier demand as cooler, drier weather and more indoor contact take hold, and Ministry of Health data indicate respiratory diseases are a major driver of pediatric emergency visits during colder months.
• Infants and older adults face the greatest risk; RSV is linked to up to 75% of bronchiolitis cases in young children, a leading cause of hospitalization in babies under one year.
• Prevention guidance stresses up‑to‑date vaccination for influenza and COVID‑19, maternal RSV immunization plus an infant immunobiologic where available, frequent hand hygiene, ventilation, masking when symptomatic, nasal saline hydration and allergen control.
• Clinicians advise early antiviral therapy for influenza when appropriate (oseltamivir within 48 hours) and urge immediate care for warning signs such as rapid breathing, chest retractions or blue lips in children, with confusion or prostration flagged in older adults.